| Autor: |
Hoffman, Risa M, Mngqibisa, Rosie, Averitt, Dawn, Currier, Judith S |
| Předmět: |
|
| Zdroj: |
Journal of the International AIDS Society; Mar2021, Vol. 24 Issue 3, p1-2, 2p |
| Abstrakt: |
Drug discovery can be accelerated by implementing incentives for moving forward with early preclinical studies on reproductive toxicity and early PK studies in pregnancy, by requiring drug developers to assess their product in pregnant and lactating women during early drug development if these preclinical and PK data are favourable, and by setting standards for a minimum number of pregnant and lactating women to be included in these early studies. Keywords: HIV; women; clinical trials; pregnancy; postpartum EN HIV women clinical trials pregnancy postpartum 1 2 2 03/31/21 20210301 NES 210301 On International Women's Day, we honour the incredible advancements in science and public health that have resulted in improved health for the more than 1.5 million women living with HIV who become pregnant each year, as well as for their children and families [1]. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
